DavidB.BregmanMDPhD

Pathology • Clarksburg, NJ

Anatomic Pathology, Clinical Pathology

Associate Clinical Professor, Pathology, Albert Einstein College of Medicine

Join to view full profile

Are you Dr. Bregman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 18 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
4 Ephraim Rd
Clarksburg, NJ 08510
Phone+1 609-276-6328

Fax+1 610-650-7781
Is this information wrong?

Summary

Dr. David Bregman, MD is a board certified pathologist in Clarksburg, New Jersey. He is currently licensed to practice medicine in New York. He is an Associate Clinical Professor at Albert Einstein College of Medicine.

Education & Training

Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1990 - 1995
Albert Einstein College of MedicineClass of 1990

Certifications & Licensure

NY State Medical License 1996 - 2025
American Board of Pathology Anatomic Pathology

Publications & Presentations

PubMed

61 citations
Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial.
Bruce W. Bode, Janet B. McGill, Daniel L. Lorber, Jorge Luiz Gross, P. C. Chang, David B. Bregman> ;Diabetes Care. 2015 Dec 1
26 citations
Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia
David B. Bregman, Lawrence T. Goodnough> ;Therapeutic Advances in Hematology. 2014 Feb 7
50 citations
Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia
Iftikhar Hussain, Jessica Bhoyroo, Angelia Butcher, Todd A. Koch, Andy He, David B. Bregman> ;Anemia. 2013 Aug 29
279 citations
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
Myles Wolf, Todd A. Koch, David B. Bregman> ;Journal of Bone and Mineral Research. 2013 Aug 1
114 citations
A multicenter, randomized, active‐controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia
Jane E. Onken, David B. Bregman, Robert A. Harrington, David C. Morris, Peter Acs, Bruce Akright, Charles Barish, Birbal S. Bhaskar, Gioi N. Smith-Nguyen, Angelia Butc...> ;Transfusion. 2013 Jun 17
22 citations
Comparative review of the safety and efficacy of ferric carboxymaltose versus standard medical care for the treatment of iron deficiency anemia in bariatric and gastri...
Margaret Malone, Charles F. Barish, Andy He, David B. Bregman> ;Obesity Surgery. 2013 Apr 4
55 citations
Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active...
Chaim Charytan, Marializa V. Bernardo, Todd A. Koch, Angelia Butcher, David Morris, David B. Bregman> ;Nephrology, Dialysis, Transplantation. 2013 Apr 1
124 citations
Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia
David B. Bregman, David C. Morris, Todd A. Koch, Andy He, Lawrence T. Goodnough> ;American Journal of Hematology. 2013 Feb 1
44 citations
Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials
Charles F. Barish, Todd A. Koch, Angelia Butcher, David Morris, David B. Bregman> ;Anemia. 2012 Sep 10
95 citations
Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.
Richard P. Allen, Charles H. Adler, Wei Du, Angelia Butcher, David B. Bregman, Christopher J. Earley> ;Sleep Medicine. 2011 Oct 1
12 citations
Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and ...
Lynda A. Szczech, David B. Bregman, Robert A. Harrington, David Morris, Angelia Butcher, Todd A. Koch, Lawrence T. Goodnough, Myles Wolf, Jane E. Onken> ;Nephrology, Dialysis, Transplantation. 2010 Jul 1
3 citations
Efficacy of cholesterol uptake inhibition added to statin therapy among subjects following a low-carbohydrate diet: a randomized controlled trial.
Julio A. Chirinos, Monica Williams, David B. Bregman, Hera Ashfaq, Umar Khayyam, Nayyar Iqbal> ;American Heart Journal. 2010 May 1
34 citations
The Inhibitor of Cyclin-Dependent Kinase 4a/Alternative Reading Frame (INK4a/ARF) Locus Encoded Proteins p16INK4a and p19ARF Repress Cyclin D1 Transcription through Di...
Mark D'Amico, Kongming Wu, Maofu Fu, Mahadev Rao, Chris Albanese, Robert G. Russell, Hanzhou Lian, David B. Bregman, Michael A. White, Richard G. Pestell> ;Cancer Research. 2004 Jun 15
47 citations
Oxaliplatin: a review of evolving concepts.
Sridhar Mani, Martin A. Graham, David B. Bregman, Percy Ivy, Stephen G. Chaney> ;Cancer Investigation. 2002 Sep 4
10 citations
RNA polymerase II large subunit is cleaved by caspases during DNA damage-induced apoptosis.
Yi Lu, Zhonghui Luo, David B. Bregman> ;Biochemical and Biophysical Research Communications. 2002 Aug 30
17 citations
Hyperphosphorylation of RNA polymerase II and reduced neuronal RNA levels precede neurofibrillary tangles in Alzheimer disease.
Jacob Husseman, Janice L. Hallows, David B. Bregman, James B. Leverenz, David Nochlin, Lee-Way Jin, Inez Vincent> ;Journal of Neuropathology and Experimental Neurology. 2001 Dec 1
17 citations
The Cockayne syndrome group B DNA repair protein as an anti-cancer target.
Yi Lu, Sridhar Mani, Ekambar R. Kandimalla, Dong Yu, Sudhir Agrawal, J. States, David B. Bregman> ;International Journal of Oncology. 2001 Dec 1
63 citations
Ultraviolet radiation alters the phosphorylation of RNA polymerase II large subunit and accelerates its proteasome-dependent degradation
Zhonghui Luo, Jianhua Zheng, Yi Lu, David B. Bregman> ;Mutation Research. 2001 Sep 4
30 citations
Disruption of the Cockayne syndrome B gene impairs spontaneous tumorigenesis in cancer-predisposed Ink4a/ARF knockout mice.
Yi Lu, H. Lian, P. Sharma, Nicole Schreiber-Agus, Robert G. Russell, Lynda Chin, G. T.J. Van Der Horst, David B. Bregman> ;Molecular and Cellular Biology. 2001 Mar 1
11 citations
Novel combinations with oxaliplatin.
Sridhar Mani, Jane Manalo, David B. Bregman> ;Oncology. 2000 Dec 1
76 citations
Limb-girdle Muscular Dystrophy (LGMD-1C) Mutants of Caveolin-3 Undergo Ubiquitination and Proteasomal Degradation TREATMENT WITH PROTEASOMAL INHIBITORS BLOCKS THE DOMI...
Ferruccio Galbiati, Daniela Volonté, Carlo Minetti, David B. Bregman, Michael P. Lisanti> ;The Journal of Biological Chemistry. 2000 Dec 1
278 citations
Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette.
Hyangkyu Lee, Daniela Volonté, Ferruccio Galbiati, Puneeth Iyengar, Douglas M. Lublin, David B. Bregman, Mark T. Wilson, Roberto Campos-Gonzalez, Boumediene Bouzahzah,...> ;Molecular Endocrinology. 2000 Nov 1
156 citations
UV-induced inhibition of transcription involves repression of transcription initiation and phosphorylation of RNA polymerase II
Davy A. P. Rockx, Rebecca Mason, Anneke van Hoffen, Michelle Craig Barton, Elisabetta Citterio, David B. Bregman, Albert A. van Zeeland, Harry Vrieling, Leon H.F. Mull...> ;Proceedings of the National Academy of Sciences of the United States of America. 2000 Sep 12
84 citations
Cell cycle regulation and RNA polymerase II.
David B. Bregman, Richard G. Pestell, Vincent J. Kidd> ;Frontiers in Bioscience. 2000 Feb 1
Pulsatile perfusion during cardiopulmonary bypass.
David B. Bregman> ;The Journal of Thoracic and Cardiovascular Surgery. 2000 Jan 1
Join now to see all

Grant Support

RNA Polymerase II And The Cellular UV ResponseNational Cancer Institute1999–2002
Flagging Of DNA Damage Sites By RNA Polymerase IINational Cancer Institute1996–1998
Sbp240--A240 KDA Pp60csrc Substrate And Binding ProteinNational Cancer Institute1994–1995
Sbp240:A240 KDA Pp60csrc Substrate And Binding ProteinNational Cancer Institute1993